The Mount Sinai-Barcelona-Milan-Broad Institute groups have proposed IGF-Akt-mTOR, Wnt-β-catenin, and IFN signaling pathways as major molecular classes in HCC [19]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.